Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04927637 · ClinicalTrials.gov registry record
ICG 24h Prior to Operative Treatment of Orthopaedic Infection
A clinical trial, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- 2
- Enrollment target
NCT04927637 is a clinical trial that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 2 participants.
The verdict
NCT04927637 has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- 2 participants
- Enrollment target
Study Summary
The focus of this study is to (1) Explore variability in distribution of 24h ICG in bone and soft tissue infection (2) Evaluate the change in 24h ICG distribution from pre to post debridement (3) Preliminarily determine whether 24h ICG has the possibility predict infection / treatment failure. Patients will be administered a single, ICG, 2.5-5mg/kg dose 24 hours prior to surgery. The patient will be prepared and transported to surgery as per routine at Dartmouth-Hitchcock. ICG fluorescence images will be acquired prior to surgical debridement.
Interventions
- PROCEDURE imaging 24 hours following intravenous administration of ICG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2021-08-13 |
| Est. Completion | 2024-03-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04927637
The ClinicalTrials.gov registry entry for NCT04927637 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which imaging 24 hours following intravenous administration of ICG is the first listed.
NCT04927637 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04927637 about?
NCT04927637 is a clinical study titled "ICG 24h Prior to Operative Treatment of Orthopaedic Infection". The focus of this study is to (1) Explore variability in distribution of 24h ICG in bone and soft tissue infection (2) Evaluate the change in 24h ICG distribution from pre to post debridement (3) Preliminarily determine whether 24h ICG has the possibility predict infection / treatment failure. Patie...
What is the current status of trial NCT04927637?
This trial is currently completed. The enrollment target is 2 participants. The study started on 2021-08-13. Estimated completion is 2024-03-09.
What interventions are being tested in trial NCT04927637?
The interventions under investigation include: imaging 24 hours following intravenous administration of ICG (PROCEDURE).
Who is sponsoring clinical trial NCT04927637?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.